Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 08, 2021

SELL
$11.73 - $16.08 $938,400 - $1.29 Million
-80,000 Closed
0 $0
Q2 2021

Aug 10, 2021

SELL
$12.85 - $16.2 $488,300 - $615,600
-38,000 Reduced 32.2%
80,000 $1.24 Million
Q1 2021

May 11, 2021

SELL
$13.84 - $17.8 $262,960 - $338,200
-19,000 Reduced 13.87%
118,000 $1.7 Million
Q4 2020

Feb 11, 2021

BUY
$12.4 - $17.6 $1.7 Million - $2.41 Million
137,000 New
137,000 $2.07 Million

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $292M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Longitude (Cayman) Ltd. Portfolio

Follow Longitude (Cayman) Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Longitude (Cayman) Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Longitude (Cayman) Ltd. with notifications on news.